Browsing by Author Taper, John

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)Citation
2017Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14Trotman, Judith; Butcher, Belinda; Cull, Gavin; et al, Various; Fay, Keith; Gandhi, Maher K.; Gill, Devinder; Hertzberg, Mark; Ho, Shir-Jing; Johnston, Amanda; Taper, John; Concord Clinical School: MedicineEarly treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14, Haematologica, vol.102, 2, 2017,pp 356-363
2015TIDEL-II: frontline use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targetsHertzberg, Mark; Taper, John; Trotman, Judith; Braley, Jodi; Branford, Susan; et al, Various; Herschtal, Alan; Hiwase, Devendra K; Issa, Samra; Kornhauser, Michael; Osborn, Michael P; Schwarer, Anthony; White, Deborah L; Yeung, David T; Western Clinical School: Medicine (Westmead); Medicine; Concord Clinical School: MedicineTIDEL-II: frontline use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets, Blood, vol.125, 6, 2015,pp 915-923